StonvexLoading…
StonvexStonvexStonvexCore line items from PENN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Q2 2022 2022-06-30 | Q1 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $6.36B | $6.40B | $3.19B | $1.56B |
Operating Income | $-690.20M | $974.00M | $594.40M | $292.00M |
Net Income | $-490.00M | $222.10M | $77.80M | $51.70M |
EPS (Diluted) | $-3.22 | $1.29 | $0.45 | $0.29 |
Total Assets | $16.06B | $17.50B | $17.88B | $18.07B |
Total Liabilities | $12.86B | $13.91B | $14.11B | $14.12B |
Cash & Equivalents | $1.07B | $1.62B | $1.71B | $1.81B |
Free Cash Flow OCF − CapEx | $95.90M | $614.80M | $310.80M | $159.30M |
Shares Outstanding | 152.10M | 176.60M | 182.30M | 184.20M |